ScholarIQanswers from OpenAlex & ORCID
Lynda E. Polgreen
ResearcherPublications, citations & collaboration network
Lynda E. Polgreen is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Lynda E. Polgreen have?
ScholarIQindexed works
Lynda E. Polgreen has 145 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Lynda E. Polgreen have?
ScholarIQcitation count
Lynda E. Polgreen has 2,318 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Lynda E. Polgreen?
ScholarIQh-index
Lynda E. Polgreen has an h-index of 27 in OpenAlex.
What is the i10-index of Lynda E. Polgreen?
ScholarIQi10-index
Lynda E. Polgreen has an i10-index of 53 in OpenAlex.
What is the ORCID of Lynda E. Polgreen?
ScholarIQorcid
The ORCID for Lynda E. Polgreen is on the source record.
What is the OpenAlex record for Lynda E. Polgreen?
ScholarIQopenalex
The OpenAlex for Lynda E. Polgreen is on the source record.
What are the most-cited papers on Lynda E. Polgreen?
ScholarIQmost cited works
Diagnosis and Management of Osteopetrosis: Consensus Guidelines From the Osteopetrosis Working Group
Calvin C. Wu, Michael J. Econs, Linda A. DiMeglio, Karl Insogna, Michael A. Levine, Paul J. Orchard, Weston P. Miller, Anna Petryk, Eric T. Rush, Dolores Shoback, Leanne M. Ward, Lynda E. Polgreen
Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial
Ravi Savarirayan, Louise Tofts, Melita Irving, William R. Wilcox, Carlos A. Bacino, Julie Hoover‐Fong, Rosendo Ullot Font, Paul Harmatz, Frank Rutsch, Michael B. Bober, Lynda E. Polgreen, Ignacio Ginebreda, Klaus Mohnike, Joel Charrow, Daniel G. Hoernschemeyer, Keiichi Ozono, Yasemin Alanay, Paul Arundel, Shoji Kagami, Natsuo Yasui, Klane K. White, Howard M. Saal, Antonio Leiva‐Gea, Felipe Luna-González, Hiroshi Mochizuki, Donald Basel, Dania M Porco, Kala Jayaram, Elena Fisheleva, Alice Huntsman-Labed, Jonathan Day
Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study
Ravi Savarirayan, Louise Tofts, Melita Irving, William R. Wilcox, Carlos A. Bacino, Julie Hoover‐Fong, Rosendo Ullot Font, Paul Harmatz, Frank Rutsch, Michael B. Bober, Lynda E. Polgreen, Ignacio Ginebreda, Klaus Mohnike, Joel Charrow, Daniel G. Hoernschemeyer, Keiichi Ozono, Yasemin Alanay, Paul Arundel, Yumiko Kotani, Natsuo Yasui, Klane K. White, Howard M. Saal, Antonio Leiva‐Gea, Felipe Luna-González, Hiroshi Mochizuki, Donald Basel, Dania M Porco, Kala Jayaram, Elena Fisheleva, Alice Huntsman-Labed, Jonathan Day
Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients
Brian McClune, Lynda E. Polgreen, Lynn A. Burmeister, Anne Blaes, Daniel A. Mulrooney, Linda J. Burns, Navneet S. Majhail
Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement
Christiane S. Hampe, Jacob Wesley, Troy C. Lund, Paul J. Orchard, Lynda E. Polgreen, Julie B. Eisengart, Linda K. McLoon, Sebahattin Cüreoğlu, Patricia A. Schachern, R. Scott McIvor